Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pandolfi, PP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Khan, MM; Nomura, T; Kim, H; Kaul, SC; Wadhwa, R; Shinagawa, T; Ichikawa-Iwata, E; Zhong, S; Pandolfi, PP; Ishii, S
      Role of PML and PML-RAR alpha in Mad-mediated transcriptional repression

      MOLECULAR CELL
    2. Merghoub, T; Gurrieri, C; Piazza, F; Pandolfi, PP
      Modeling acute promyelocytic leukemia in the mouse: New insights in the pathogenesis of human leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    3. Costoya, JA; Pandolfi, PP
      The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development

      CURRENT OPINION IN HEMATOLOGY
    4. Di Cristofano, A; De Acetis, M; Koff, A; Cordon-Cardo, C; Pandolfi, PP
      Pten and p27(KIP1) cooperate in prostate cancer tumor suppression in the mouse

      NATURE GENETICS
    5. Pandolfi, PP
      Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia

      HUMAN MOLECULAR GENETICS
    6. Hu, P; Beresten, SF; van Brabant, AJ; Ye, TZ; Pandolfi, PP; Johnson, FB; Guarente, L; Ellis, NA
      Evidence for BLM and Topoisomerase III alpha interaction in genomic stability

      HUMAN MOLECULAR GENETICS
    7. Wu, XM; Pandolfi, PP
      Mouse models for multistep tumorigenesis

      TRENDS IN CELL BIOLOGY
    8. Piazza, F; Gurrieri, C; Pandolfi, PP
      The theory of APL

      ONCOGENE
    9. Pandolfi, PP
      In vivo analysis of the molecular genetics of acute promyelocytic leukemia

      ONCOGENE
    10. Pandolfi, PP
      Transcription therapy for cancer

      ONCOGENE
    11. Lehembre, F; Muller, S; Pandolfi, PP; Dejean, A
      Regulation of Pax3 transcriptional activity by SUMO-1-modified PML

      ONCOGENE
    12. Gaboli, M; Kotsi, PA; Gurrieri, C; Cattoretti, G; Ronchetti, S; Cordon-Cardo, C; Broxmeyer, HE; Hromas, R; Pandolfi, PP
      Mzf1 controls cell proliferation and tumorigenesis

      GENES & DEVELOPMENT
    13. Pandolfi, PP
      Histone deacetylases and transcriptional therapy with their inhibitors

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    14. Regad, T; Saib, A; Lallemand-Breitenbach, V; Pandolfi, PP; de The, H; Chelbi-Alix, MK
      PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator

      EMBO JOURNAL
    15. Rego, EM; Pandolfi, PP
      Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models

      SEMINARS IN HEMATOLOGY
    16. Liao, C; Wang, XY; Wei, HQ; Li, SQ; Merghoub, T; Pandolfi, PP; Wolgemuth, DJ
      Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    17. Djavani, M; Rodas, J; Lukashevich, IS; Horejsh, D; Pandolfi, PP; Borden, KLB; Salvato, MS
      Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus

      JOURNAL OF VIROLOGY
    18. Keller, P; Payne, JL; Tremml, G; Greer, PA; Gaboli, M; Pandolfi, PP; Bessler, M
      FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation tohematopoietic stem cells in the bone marrow

      JOURNAL OF EXPERIMENTAL MEDICINE
    19. Zhao, MM; Schmitz, AAP; Qin, Y; Di Cristofano, A; Pandolfi, PP; Van Aelst, L
      Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation

      JOURNAL OF EXPERIMENTAL MEDICINE
    20. Di Cristofano, A; Niki, M; Zhao, MM; Karnell, FG; Clarkson, B; Pear, WS; Van Aelst, L; Pandolfi, PP
      p62(dok), a negative regulator of Ras and mitogen-activated protein kinase(MAPK) activity, opposes leukemogenesis by p210(bcr-abl)

      JOURNAL OF EXPERIMENTAL MEDICINE
    21. Rego, EM; Wang, ZG; Peruzzi, D; He, LZ; Cordon-Cardo, C; Pandolfi, PP
      Role of promyelocytic leukemia (PML) protein in tumor suppression

      JOURNAL OF EXPERIMENTAL MEDICINE
    22. Lallemand-Breitenbach, V; Zhu, J; Puvion, F; Koken, M; Honore, N; Doubeikovsky, A; Duprez, E; Pandolfi, PP; Puvion, E; Freemont, P; de The, H
      Role of promyelocytic leukemia (PML) sumolation in nuclear body formation,11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

      JOURNAL OF EXPERIMENTAL MEDICINE
    23. He, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
      Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia

      JOURNAL OF CLINICAL INVESTIGATION
    24. Khan, MM; Nomura, T; Kim, H; Kaul, SC; Wadhwa, R; Zhong, S; Pandolfi, PP; Ishi, S
      PML-RAR alpha alleviates the transcriptional repression mediated by tumor suppressor Rb

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Ward, JO; McConnell, MJ; Carlile, GW; Pandolfi, PP; Licht, JD; Freedman, LP
      The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D-3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D-3 receptor

      BLOOD
    26. Toney, LM; Cattoretti, G; Graf, JA; Merghoub, T; Pandolfi, PP; Dalla-Favera, R; Ye, BH; Dent, AL
      BCL-6 regulates chemokine gene transcription in macrophages

      NATURE IMMUNOLOGY
    27. Zhong, S; Salomoni, P; Pandolfi, PP
      The transcriptional role of PML and the nuclear body

      NATURE CELL BIOLOGY
    28. Guo, A; Salomoni, P; Luo, JY; Shih, A; Zhong, S; Gu, W; Pandolfi, PP
      The function of PML in p53-dependent apoptosis

      NATURE CELL BIOLOGY
    29. He, LZ; Bhaumik, M; Tribioli, C; Rego, EM; Ivins, S; Zelent, A; Pandolfi, PP
      Two critical hits for promyelocytic leukemia

      MOLECULAR CELL
    30. Salomoni, P; Pandolfi, PP
      Transcriptional regulation of cellular transformation

      NATURE MEDICINE
    31. Barna, M; Hawe, N; Niswander, L; Pandolfi, PP
      Plzf regulates limb and axial skeletal patterning

      NATURE GENETICS
    32. Ruggero, D; Wang, ZG; Pandolfi, PP
      The puzzling multiple lives of PML and its role in the genesis of cancer

      BIOESSAYS
    33. Fogal, V; Gostissa, M; Sandy, P; Zacchi, P; Sternsdorf, T; Jensen, K; Pandolfi, PP; Will, H; Schneider, C; Del Sal, G
      Regulation of p53 activity in nuclear bodies by a specific PML isoform

      EMBO JOURNAL
    34. Di Cristofano, A; Pandolfi, PP
      The multiple roles of PTEN in tumor suppression

      CELL
    35. Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG
      PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

      NATURE
    36. Rego, EM; He, LZ; Warrell, RP; Wang, ZG; Pandolfi, PP
      Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RAR alpha and PLZF-RAR alpha oncoproteins

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    37. Zhong, S; Salomoni, P; Ronchetti, S; Guo, A; Ruggero, D; Pandolfi, PP
      Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

      JOURNAL OF EXPERIMENTAL MEDICINE
    38. Arpaia, E; Benveniste, P; Di Cristofano, A; Gu, YP; Dalal, I; Kelly, S; Hershfield, M; Pandolfi, PP; Roifman, CM; Cohen, A
      Mitochondrial basis for immune deficiency: Evidence from purine nucleosidephosphorylase-deficient mice

      JOURNAL OF EXPERIMENTAL MEDICINE
    39. Zhong, S; Muller, S; Ronchetti, S; Freemont, PS; Dejean, A; Pandolfi, PP
      Role of SUMO-1-modified PML in nuclear body formation

      BLOOD
    40. Zhong, S; Delva, L; Rachez, C; Cenciarelli, C; Gandini, D; Zhang, H; Kalantry, S; Freedman, LP; Pandolfi, PP
      A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RAR alpha and T18 oncoproteins

      NATURE GENETICS
    41. Zong, S; Hu, P; Ye, TZ; Stan, R; Ellis, NA; Pandolfi, PP
      A role for PML and the nuclear body in genomic stability

      ONCOGENE
    42. He, LZ; Merghoub, T; Pandolfi, PP
      In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

      ONCOGENE
    43. Tsutsui, T; Hesabi, B; Moons, DS; Pandolfi, PP; Hansel, KS; Koff, A; Kiyokawa, H
      Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity

      MOLECULAR AND CELLULAR BIOLOGY
    44. Harris, MB; Chang, CC; Berton, MT; Danial, KN; Zhang, JD; Kuehner, D; Ye, BH; Kvatyuk, M; Pandolfi, PP; Cattoretti, G; Dalla-Favera, R; Rothman, PB
      Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: Specific regulation of I epsilon transcription and immunoglobulinE switching

      MOLECULAR AND CELLULAR BIOLOGY
    45. Di Cristofano, A; Kotsi, P; Peng, YF; Cordon-Cardo, C; Elkon, KB; Pandolfi, PP
      Impaired Fas response and autoimmunity in Pten(+/-) mice

      SCIENCE
    46. Warrell, RP; Pandolfi, PP
      Treatment of acute promyelocytic leukemia with arsenic trioxide - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    47. Migliaccio, E; Giorgio, M; Mele, S; Pelicci, G; Reboidl, P; Pandolfi, PP; Lanfrancone, L; Pelicci, PG
      The p66(shc) adaptor protein controls oxidative stress response and life span in mammals

      NATURE
    48. Tremml, G; Dominguez, C; Rosti, V; Zhang, Z; Pandolfi, PP; Keller, P; Bessler, M
      Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene

      BLOOD
    49. WANG ZG; RUGGERO D; RONCHETTI S; ZHONG S; GABOLI M; RIVI R; PANDOLFI PP
      PML IS ESSENTIAL FOR MULTIPLE APOPTOTIC PATHWAYS

      Nature genetics
    50. DICRISTOFANO A; PESCE B; CORDONCARDO C; PANDOLFI PP
      PTEN IS ESSENTIAL FOR EMBRYONIC-DEVELOPMENT AND TUMOR SUPPRESSION

      Nature genetics
    51. BOTTO M; DELLAGNOLA C; BYGRAVE AE; THOMPSON EM; COOK HT; PETRY F; LOOS M; PANDOLFI PP; WALPORT MJ
      HOMOZYGOUS C1Q DEFICIENCY CAUSES GLOMERULONEPHRITIS ASSOCIATED WITH MULTIPLE APOPTOTIC BODIES

      Nature genetics
    52. HE LZ; GUIDEZ F; TRIBIOLI C; PERUZZI D; RUTHARDT M; ZELENT A; PANDOLFI PP
      DISTINCT INTERACTIONS OF PML-RAR-ALPHA AND PLZF-RAR-ALPHA WITH CO-REPRESSORS DETERMINE DIFFERENTIAL RESPONSES TO RA IN APL

      Nature genetics
    53. GABOLI M; GANDINI D; DELVA L; WANG ZG; PANDOLFI PP
      ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS

      Leukemia & lymphoma
    54. LEMBO M; SACCHI C; ZAPPADOR C; BELLOMO G; GABOLI M; PANDOLFI PP; GARIGLIO M; LANDOLFO S
      INHIBITION OF CELL-PROLIFERATION BY THE INTERFERON-INDUCIBLE 204-GENE, A MEMBER OF THE IFI-200 CLUSTER

      Oncogene
    55. SOIGNET SL; MASLAK P; CHEN YW; CALLEJA E; PANDOLFI PP; SCHEINBERG DA; WARRELL RP
      WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/

      Annals of oncology
    56. PANDOLFI PP
      KNOCKING IN AND OUT GENES AND TRANS GENES - THE USE OF THE ENGINEEREDMOUSE TO STUDY NORMAL AND ABERRANT HEMATOPOIESIS

      Seminars in hematology
    57. WANG ZG; DELVA L; GABOLI M; RIVI R; GIORGIO M; CORDONCARDO C; GROSVELD F; PANDOLFI PP
      ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY

      Science
    58. SOIGNET SL; MASLAK P; WANG ZG; JHANWAR S; CALLEJA E; DARDASHTI LJ; CORSO D; DEBLASIO A; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE

      The New England journal of medicine
    59. DICRISTOFANO A; CARPINO N; DUNANT N; FRIEDLAND G; KOBAYASHI R; STRIFE A; WISNIEWSKI D; CLARKSON B; PANDOLFI PP; RESH MD
      MOLECULAR-CLONING AND CHARACTERIZATION OF P56(DOK-2) DEFINES A NEW FAMILY OF RASGAP-BINDING PROTEINS

      The Journal of biological chemistry
    60. FARIA TN; RIVI R; DERGUINI F; PANDOLFI PP; GUDAS LJ
      4-OXORETINOL, A METABOLITE OF RETINOL IN THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE NB4, INDUCES CELL-GROWTH ARREST AND GRANULOCYTIC DIFFERENTIATION

      Cancer research
    61. SOIGNET SL; MASLAK P; CHEN YW; CALLEJA E; PANDOLFI PP; SCHEINBERG DA; WARRELL RP
      COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE

      British Journal of Haematology
    62. WANG ZG; RIVI R; DELVA L; KONIG A; SCHEINBERG DA; GAMBACORTIPASSERINI C; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML-RAR-ALPHA INDEPENDENT MANNER

      Blood
    63. WARRELL RP; HE LZ; RICHON V; CALLEJA E; PANDOLFI PP
      THERAPEUTIC TARGETING OF TRANSCRIPTION IN ACUTE PROMYELOCYTIC LEUKEMIA BY USE OF AN INHIBITOR OF HISTONE DEACETYLASE

      Journal of the National Cancer Institute
    64. YE BH; CATTORETTI G; SHEN QO; ZHANG JD; HAWE N; DEWAARD R; LEUNG C; NOURISHIRAZI M; ORAZI A; CHAGANTI RSK; ROTHMAN P; STALL AM; PANDOLFI PP; DALLAFAVERA R
      THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION

      Nature genetics
    65. LONGO L; BYGRAVE A; GROSVELD FG; PANDOLFI PP
      THE CHROMOSOME MAKE-UP OF MOUSE EMBRYONIC STEM-CELLS IS PREDICTIVE OFSOMATIC AND GERM-CELL CHIMERISM

      Transgenic research
    66. HE LZ; TRIBIOLI C; RIVI R; PERUZZI D; PELICCI PG; SOARES V; CATTORETTI G; PANDOLFI PP
      ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    67. ROSTI V; TREMML G; SOARES V; PANDOLFI PP; LUZZATTO L; BESSLER M
      MURINE EMBRYONIC STEM-CELLS WITHOUT PIG-A GENE ACTIVITY ARE COMPETENTFOR HEMATOPOIESIS WITH THE PNH PHENOTYPE BUT NOT FOR CLONAL EXPANSION

      The Journal of clinical investigation
    68. KALANTRY S; DELVA L; GABOLI M; GANDINI D; GIORGIO M; HAWE N; HE LZ; PERUZZI D; RIVI R; TRIBIOLI C; WANG ZG; ZHANG H; PANDOLFI PP
      GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA

      Journal of cellular physiology
    69. KONIG A; WRAZEL L; WARRELL RP; RIVI R; PANDOLFI PP; JAKUBOWSKI A; GABRILOVE JL
      COMPARATIVE ACTIVITY OF MELARSOPROL AND ARSENIC TRIOXIDE IN CHRONIC B-CELL LEUKEMIA LINES

      Blood
    70. KLEMSZ MJ; GABOLI M; HROMAS R; PANDOLFI PP
      EXPRESSION OF PU.1 IN THE THYMUS RESULTS IN ALTERED T-CELL DEVELOPMENT

      Blood
    71. HE LZ; PERUZZI D; TRIBIOLI C; WARRELL RP; PANDOLFI PP
      THERAPEUTIC TRIALS WITH RETINOIC ACID AND ARSENIC TRIOXIDE (ASO3) IN PML-RAR-ALPHA AND PLZF-RAR-ALPHA TRANSGENIC MICE AS MODELS OF APL

      Blood
    72. HE LZ; TRIBIOLI C; PERUZZI D; RUTHARD M; CATTORETTI G; PANDOLFI PP
      MYELOID-LEUKEMIA IN PLZF RAR-ALPHA TRANSGENIC MICE/

      Blood
    73. WANG ZG; RIVI R; DELVA L; KONIG A; SOIGNET S; SCHEINBERG D; GAMBACORTIPASSERINI C; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/

      Blood
    74. TREMML G; ROSTI V; SOAREZ V; PANDOLFI PP; BESSLER M
      INACTIVATION OF PIG-A IN HEMATOPOIETIC STEM-CELLS OBTAINED BY CRE-LOXP MEDIATED RECOMBINATION - A MOUSE MODEL FOR PNH

      Blood
    75. LONGO L; ROSTI V; GABOLI M; TABARINI D; PANDOLFI PP; LUZZATTO L
      MICE HETEROZYGOUS FOR COMPLETE GLUCOSE-6-PHOSPHATE-DEHYDROGENASE (G6PD) DEFICIENCY ARE VIABLE AND SHOW SOMATIC-CELL SELECTION

      Blood
    76. SOIGNET SL; RIVI R; KONIG A; TONG WP; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      MELARSOPROL, AN ORGANIC ARSENICAL, IN THE TREATMENT OF REFRACTORY LEUKEMIA - LABORATORY AND CLINICAL-RESULTS

      Blood
    77. GABOLI M; CATTORETTI G; BROXMEYER HE; HROMAS R; PANDOLFI PP
      TARGETED DISRUPTION OF THE MYELOID ZINC FINGER-1 (MZF-1) GENE RESULTSIN INCREASED PROLIFERATION OF HEMATOPOIETIC PRECURSORS

      Blood
    78. BOTTO M; DELLAGNOLA C; PANDOLFI PP; BYGRAVE A; THOMPSON M; PETRY F; LOOS M; WALPORT MJ
      HOMOZYGOUS C1Q DEFICIENCY - A CAUSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN HUMANS AND MICE

      Arthritis and rheumatism
    79. PELICCI G; DENTE L; DEGIUSEPPE A; VERDUCCIGALLETTI B; GIULI S; MELE S; VETRIANI C; GIORGIO M; PANDOLFI PP; CESARENI G; PELICCI PG
      A FAMILY OF SHC RELATED PROTEINS WITH CONSERVED PTB, CH1 AND SH2 REGIONS

      Oncogene
    80. PANDOLFI PP
      PML, PLZF AND NPM GENES IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA

      Haematologica
    81. BESSLER M; ROSTI V; TREMML G; SOARES V; PANDOLFI PP; LUZZATTO L
      MICE WITH HEMATOPOIESIS DEFICIENT IN GLYCOSYL PHOSPHATIDYLINOSITOL (GPI) LINKED MOLECULES - A POSSIBLE MODEL FOR PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA (PNH)

      Experimental hematology
    82. SEALE JRC; VARMA S; SWIRSKY DM; PANDOLFI PP; GOLDMAN JM; CROSS NCP
      QUANTIFICATION OF PML-RAR-ALPHA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA - EXPLANATION FOR THE LACK OF SENSITIVITY OF RT-PCR FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE AND INDUCTION OF THE LEUKEMIA-SPECIFIC MESSENGER-RNA BY ALPHA-INTERFERON

      British Journal of Haematology
    83. RIVI R; CALLEJA E; KONIG A; LAI L; GAMBACORTIPASSERINI C; SCHEINBERG D; GABRILOVE JL; WARRELL RP; PANDOLFI PP
      ORGANIC ARSENICAL MELARSOPROL SHOWS GROWTH SUPPRESSIVE ACTIVITY VIA PROGRAMMED CELL-DEATH ON APL AND OTHER MYELOID AND LYMPHOID LEUKEMIA-DERIVED CELL-LINES

      Blood
    84. CATTORETTI G; YE BH; HAWE N; NOURISHIRAZI M; STALL A; CHAGANTI RSK; PANDOLFI PP; DALLAFAVERA R
      BCL-6 IS INVOLVED IN GERMINAL CENTER FORMATION

      Blood
    85. SOIGNET S; TONG WP; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      INITIAL CLINICAL-STUDY OF A NOVEL ORGANIC ARSENICAL, MELARSOPROL, IN PATIENTS WITH ADVANCED LEUKEMIA

      Blood
    86. HAWE N; SOARES V; NISWANDER L; CATTORETTI G; PANDOLFI PP
      TARGETED DISRUPTION OF THE PLZF GENE OF ACUTE PROMYELOCYTIC LEUKEMIA RESULTS IN PHOCOMELIA AND ALTERED SPERMATOGENESIS

      Blood
    87. LONGO L; GIORGIO M; SOARES V; TABARINI D; PANDOLFI PP; LUZZATTO L
      IN-VIVO DISRUPTION OF THE GENE ENCODING GLUCOSE-6-PHOSPHATE-DEHYDROGENASE (G6PD)

      Blood
    88. PERUZZI D; DEBLASIO T; WARRELL RP; PANDOLFI PP
      HIGHLY SENSITIVE RT-PCR ASSAY FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    89. BESSLER M; ROSTI V; TREMML G; SOARES V; PANDOLFI PP; LUZZATTO L
      HEMATOPOIESIS WITH THE PNH PHENOTYPE IN MICE CHIMERIC FOR A NON FUNCTIONAL PIG-A GENE

      Blood
    90. WANG ZG; GIORGIO M; RIVI R; CORDONCARDO C; GABELI M; PANDOLFI PP
      GROWTH AND TUMOR SUPPRESSIVE PROPERTIES OF THE PML GENE OF ACUTE PROMYELOCYTIC LEUKEMIA IN PML- - MICE/

      Blood
    91. KONIG A; WRAZEL L; WARRELL RP; PANDOLFI PP; RIVI R; ALKATIB A; GABRILOVE JL
      IN-VITRO EFFECTS OF MELARSOPROL AS COMPARED TO ARSENIC TRIOXIDE (AS2O3) IN CHRONIC LYMPHOID MALIGNANCIES

      Blood
    92. NASONBURCHENAL K; GANDINI D; BOTTO M; ALLOPENNA J; SEALE JRC; CROSS NCP; GOLDMAN JM; DMITROVSKY E; PANDOLFI PP
      INTERFERON AUGMENTS PML AND PML RAR-ALPHA EXPRESSION IN NORMAL MYELOID AND ACUTE PROMYELOCYTIC CELLS AND COOPERATES WITH ALL-TRANS-RETINOICACID TO INDUCE MATURATION OF A RETINOID-RESISTANT PROMYELOCYTIC CELL-LINE/

      Blood
    93. PANDOLFI PP; ROTH ME; KARIS A; LEONARD MW; DZIERZAK E; GROSVELD FG; ENGEL JD; LINDENBAUM MH
      TARGETED DISRUPTION OF THE GATA3 GENE CAUSES SEVERE ABNORMALITIES IN THE NERVOUS-SYSTEM AND IN FETAL LIVER HEMATOPOIESIS

      Nature genetics
    94. LAVAU C; MARCHIO A; FAGIOLI M; JANSEN J; FALINI B; LEBON P; GROSVELD F; PANDOLFI PP; PELICCI PG; DEJEAN A
      THE ACUTE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PML GENE IS INDUCED BY INTERFERON

      Oncogene
    95. MAHER J; PANDOLFI PP; ROBERTS IAG
      SELECTION OF A HIGHLY ENRICHED POPULATION OF RETROVIRUS-INFECTED HUMAN HEMATOPOIETIC PROGENITOR CELLS USING SNL FIBROBLASTS

      Leukemia
    96. AVANTAGGIATO V; PANDOLFI PP; RUTHARDT M; HAWE N; ACAMPORA D; PELICCI PG; SIMEONE A
      DEVELOPMENTAL ANALYSIS OF MURINE PROMYELOCYTE LEUKEMIA ZINC-FINGER (PLZF) GENE-EXPRESSION - IMPLICATIONS FOR THE NEUROMERIC MODEL OF THE FOREBRAIN ORGANIZATION

      The Journal of neuroscience
    97. PANDOLFI PP; SONATI F; RIVI R; MASON P; GROSVELD F; LUZZATTO L
      TARGETED DISRUPTION OF THE HOUSEKEEPING GENE ENCODING GLUCOSE-6-PHOSPHATE-DEHYDROGENASE (G6PD) - G6PD IS DISPENSABLE FOR PENTOSE SYNTHESIS BUT ESSENTIAL FOR DEFENSE AGAINST OXIDATIVE STRESS

      EMBO journal
    98. HAWE N; PANDOLFI PP
      TARGETED DISRUPTION OF THE PLZF GENE OF ACUTE PROMYELOCYTIC LEUKEMIA

      Blood
    99. NASONBURCHENAL K; GANDINI D; BOTTO M; ALLOPENNA J; SEALE JRC; CROSS NCP; GOLDMAN JM; DMITROVSKY E; PANDOLFI PP
      INTERFERON AUGMENTS PML AND PML RAR-ALPHA EXPRESSION IN NORMAL MYELOID AND ACUTE PROMYELOCYTIC CELLS AND COOPERATES WITH ALL-TRANS-RETINOICACID TO INDUCE MATURATION OF A RETINOID RESISTANT PROMYELOCYTIC CELL-LINE/

      Blood
    100. PANDOLFI PP; RIVI R; GABOLI M; GIORGIO M; ANTONIOU M; BYGRAVE A; FAGIOLI M; CORDONCARDO C; PELICCI PG; LUZZATTO L; GROSVELD F
      TARGETED DISRUPTION OF THE PML GENE OF ACUTE PROMYELOCYTIC LEUKEMIA

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 14:00:23